Visualizing molecular profiles of glioblastoma with GBM-BioDP

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Celiku, Orieta ^a   Johnson, Seth ^b   Zhao, Shuping ^a   Camphausen, Kevin ^a   Shankavaram, Uma ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b United States Government Printing Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN34 MICRORNA, HUMAN;

ARTICLE; CANCER GROWTH; DATA BASE; GENE EXPRESSION; GLIOBLASTOMA; GLIOBLASTOMA BIO DISCOVERY PORTAL DATABASE; HUMAN; INTERNET; MATHEMATICAL ANALYSIS; MICROARRAY ANALYSIS; NERVOUS SYSTEM DEVELOPMENT; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; VALIDATION PROCESS; BRAIN NEOPLASMS; FACTUAL DATABASE; GENE EXPRESSION PROFILING; GENETICS; GENOMICS; PATHOLOGY; PROCEDURES; SURVIVAL; TUMOR GENE;

BRAIN NEOPLASMS; DATABASES, FACTUAL; GENE EXPRESSION PROFILING; GENES, NEOPLASM; GENOMICS; GLIOBLASTOMA; HUMANS; MICRORNAS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84904253102     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101239     Document Type: Article

References (30)

1. Network CGAR (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996. (Pubitemid 40349501)
3. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, et al. (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352: 997-1003. (Pubitemid 40349502)
4. Addeo R, De Santi MS, Del Prete S, Caraglia M (2009) Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug. Cancer Chemother Pharmacol 64: 863-866.
5. Addeo R, Caraglia M, De Santi MS, Montella L, Abbruzzese A, et al. (2011) A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma. J Neurooncol 102: 417-424.
6. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110.
7. Olar A, Aldape KD (2014) Using the molecular classification of glioblastoma to inform personalized treatment. J Pathol 232: 165-177.
8. Schroeder MP, Gonzalez-Perez A, Lopez-Bigas N (2013) Visualizing multidimensional cancer genomics data. Genome Med 5: 9.
9. Thorvaldsdóttir H, Robinson JT, Mesirov JP (2013) Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14: 178-192.
10. Fiume M, Smith EJ, Brook A, Strbenac D, Turner B, et al. (2012) Savant Genome Browser 2: visualization and analysis for population-scale genomics. Nucleic Acids Res 40: W615-621.
11. Cline MS, Craft B, Swatloski T, Goldman M, Ma S, et al. (2013) Exploring TCGA Pan-Cancer data at the UCSC Cancer Genomics Browser. Sci Rep 3: 2652.
12. Sanborn JZ, Benz SC, Craft B, Szeto C, Kober KM, et al. (2011) The UCSC Cancer Genomics Browser: update 2011. Nucleic Acids Res 39: D951-959.
13. Perez-Llamas C, Lopez-Bigas N (2011) Gitools: analysis and visualisation of genomic data using interactive heat-maps. PLoS One 6: e19541.
14. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, et al. (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2: 401-404.
15. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, et al. (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6: pl1.
16. Lex A, Streit M, Schulz HJ, Partl C, Schmalstieg D, et al. (2012) StratomeX: Visual Analysis of Large-Scale Heterogeneous Genomics Data for Cancer Subtype Characterization. Computer Graphics Forum. 1175-1184.
17. Vaske CJ, Benz SC, Sanborn JZ, Earl D, Szeto C, et al. (2010) Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics 26: i237-245.
18. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13: 2498-2504. (Pubitemid 37428274)
19. Shannon PT, Grimes M, Kutlu B, Bot JJ, Galas DJ (2013) RCytoscape: tools for exploratory network analysis. BMC Bioinformatics 14: 217.
20. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
21. Tibshirani R, Hastie T, Narasimhan B, Chu G (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 99: 6567-6572. (Pubitemid 34526173)
22. Liaw A, Wiender M (2002) Classification and Regression by randomForest. R News 2: 18-22.
23. Team RC (2013) R: A language and environment for statistical computing.
24. Weller M, Felsberg J, Hartmann C, Berger H, Steinbach JP, et al. (2009) Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. J Clin Oncol 27: 5743-5750.
25. Kozomara A, Griffiths-Jones S (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: D152-157.
26. Genovese G, Ergun A, Shukla SA, Campos B, Hanna J, et al. (2012) microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma. Cancer Discov 2: 736-749.
27. Sasaki A, Udaka Y, Tsunoda Y, Yamamoto G, Tsuji M, et al. (2012) Analysis of p53 and miRNA expression after irradiation of glioblastoma cell lines. Anticancer Res 32: 4709-4713.
28. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157-173. (Pubitemid 43357943)
29. Raza SM, Fuller GN, Rhee CH, Huang S, Hess K, et al. (2004) Identification of necrosis-associated genes in glioblastoma by cDNA microarray analysis. Clin Cancer Res 10: 212-221. (Pubitemid 38114182)
30. Hammoud MA, Sawaya R, Shi W, Thall PF, Leeds NE (1996) Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol 27: 65-73. (Pubitemid 26052641)